Where I see patients (1)
Molecular and Radiological Features of Microsatellite Stable Colorectal Cancer Cases With Dramatic Responses to Immunotherapy.
Pragmatic Solutions to Counteract the Regressive Effects of the COVID-19 Pandemic for Women in Academic Oncology.
Key challenges for drugs in clinical development for cholangiocarcinoma.
Expert opinion on investigational drugs
A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer
An AE is any untoward medical occurrence in a subject or clinical investigational subject administered a medicinal product and which does not necessarily have a causal relationship with this treatment.